Literature DB >> 28975618

The CDK inhibitor p21 is a novel target gene of ATF4 and contributes to cell survival under ER stress.

Yasumichi Inoue1,2, Shiori Kawachi1, Tsubasa Ohkubo1, Mai Nagasaka1, Shogo Ito1, Keishi Fukuura1, Yuka Itoh1,2, Nobumichi Ohoka3, Daisuke Morishita1, Hidetoshi Hayashi1,2.   

Abstract

Activating transcription factor 4 (ATF4) is well known for its role in the endoplasmic reticulum (ER) stress response. ATF4 also transcriptionally induces multiple effectors that determine cell fate depending on cellular context. In addition, ATF4 can communicate both pro-apoptotic and pro-survival signals. How ATF4 mediates its prosurvival roles, however, requires further investigation. Here, we report that the CDK inhibitor p21 is a novel target gene of ATF4. We identified two ATF4-responsive elements, one of which directly binds ATF4, within the first intron of the p21 gene. Importantly, overexpression of p21 enhances cell survival following ER stress induction, while p21 knockdown increases cell death. These results suggest that p21 induction plays a vital role in the cellular response to ER stress and indicate that p21 is a prosurvival effector of ATF4.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  ATF4; ER stress; p21

Mesh:

Substances:

Year:  2017        PMID: 28975618     DOI: 10.1002/1873-3468.12869

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction.

Authors:  Fernando Lopes; Åsa V Keita; Alpana Saxena; Jose Luis Reyes; Nicole L Mancini; Ala Al Rajabi; Arthur Wang; Cristiane H Baggio; Michael Dicay; Rob van Dalen; Younghee Ahn; Matheus B H Carneiro; Nathan C Peters; Jong M Rho; Wallace K MacNaughton; Stephen E Girardin; Humberto Jijon; Dana J Philpott; Johan D Söderholm; Derek M McKay
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

2.  The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing p21.

Authors:  Keishi Fukuura; Yasumichi Inoue; Chiharu Miyajima; Shin Watanabe; Muneshige Tokugawa; Daisuke Morishita; Nobumichi Ohoka; Masayuki Komada; Hidetoshi Hayashi
Journal:  J Biol Chem       Date:  2019-09-18       Impact factor: 5.157

3.  Splice switching an oncogenic ratio of SmgGDS isoforms as a strategy to diminish malignancy.

Authors:  Anthony C Brandt; Lisa McNally; Ellen L Lorimer; Bethany Unger; Olivia J Koehn; Kiall F Suazo; Lisa Rein; Aniko Szabo; Shirng-Wern Tsaih; Mark D Distefano; Michael J Flister; Frank Rigo; Mark T McNally; Carol L Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-04       Impact factor: 11.205

Review 4.  Skeletal Muscle Atrophy: Discovery of Mechanisms and Potential Therapies.

Authors:  Scott M Ebert; Asma Al-Zougbi; Sue C Bodine; Christopher M Adams
Journal:  Physiology (Bethesda)       Date:  2019-07-01

5.  CCDC106 promotes the proliferation and invasion of ovarian cancer cells by suppressing p21 transcription through a p53-independent pathway.

Authors:  Na Zhao; Chen Wang; Peng Guo; Jun Hou; Hong Yang; Ting Lan; Yehan Zhou; Jiayu Li; Ujjal K Bhawal; Yang Liu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  Spontaneously slow-cycling subpopulations of human cells originate from activation of stress-response pathways.

Authors:  Mingwei Min; Sabrina L Spencer
Journal:  PLoS Biol       Date:  2019-03-13       Impact factor: 8.029

7.  An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy.

Authors:  Cedric Darini; Nour Ghaddar; Catherine Chabot; Gloria Assaker; Siham Sabri; Shuo Wang; Jothilatha Krishnamoorthy; Marguerite Buchanan; Adriana Aguilar-Mahecha; Bassam Abdulkarim; Jean Deschenes; Jose Torres; Josie Ursini-Siegel; Mark Basik; Antonis E Koromilas
Journal:  Nat Commun       Date:  2019-05-13       Impact factor: 14.919

8.  Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence.

Authors:  Chiharu Miyajima; Yuki Kawarada; Yasumichi Inoue; Chiaki Suzuki; Kana Mitamura; Daisuke Morishita; Nobumichi Ohoka; Takeshi Imamura; Hidetoshi Hayashi
Journal:  Cells       Date:  2020-01-09       Impact factor: 6.600

9.  Anti-Tumorigenic Activity of Chrysin from Oroxylum indicum via Non-Genotoxic p53 Activation through the ATM-Chk2 Pathway.

Authors:  Mai Nagasaka; Ryoko Hashimoto; Yasumichi Inoue; Kan'ichiro Ishiuchi; Michiyo Matsuno; Yuka Itoh; Muneshige Tokugawa; Nobumichi Ohoka; Daisuke Morishita; Hajime Mizukami; Toshiaki Makino; Hidetoshi Hayashi
Journal:  Molecules       Date:  2018-06-08       Impact factor: 4.411

10.  Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBPβ.

Authors:  Scott M Ebert; Steven A Bullard; Nathan Basisty; George R Marcotte; Zachary P Skopec; Jason M Dierdorff; Asma Al-Zougbi; Kristin C Tomcheck; Austin D DeLau; Jacob A Rathmacher; Sue C Bodine; Birgit Schilling; Christopher M Adams
Journal:  J Biol Chem       Date:  2020-01-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.